Effect of thrombin inhibitors and a glycoprotein IIb/IIIa receptor antagonist in an ex vivo human experimental thrombosis model

Seminars in Thrombosis and Hemostasis

Volumn 27, Issue 5, 2001, Pages 531-536

  Zokai, K ^a   Piazolo, L ^a   Harenberg, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Blood coagulation; GPIIb IIIa antagonist; Platelets; Thrombin inhibitors; Thrombosis model

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; DALTEPARIN; DANAPAROID; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HEPARINOID; HIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT HIRUDIN; THROMBIN INHIBITOR;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; DRUG EFFICACY; EXPERIMENTAL MODEL; HUMAN; HUMAN EXPERIMENT; MEDICAL RESEARCH; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SPECIES DIFFERENCE; THROMBOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTITHROMBIN III; ANTITHROMBINS; BLOOD COAGULATION TESTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HEPARINOIDS; HIRUDINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PEPTIDE HYDROLASES; PLATELET AGGREGATION INHIBITORS; PLATELET FACTOR 4; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REPRODUCIBILITY OF RESULTS; THROMBIN; THROMBOSIS;

EID: 0034777137     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17963     Document Type: Article

References (28)

1. Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor
2. Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin
3. Pharmacological characterization of a new 4-amidinophenylalanine thrombininhibitor (CRC 220)
4. Antithromboric effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs
5. GPIIb/IIIa antagonists: Pathophysiologic and therapeutic insights from studies of c7E3 Fab
6. In vitro effects of platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time
7. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody
8. Experimental models of arterial thrombosis
9. Thrombosis in unstable angina
10. Role of platelets and vascular eicosanoids in the pathophysiology of ischemic heart disease
11. New insights into mechanism of platelet adhesion and aggregation
12. Interaction of blood platelets with the vessel wall
13. Cell biology of endothelial cells
14. Platelet adhesion
15. Measurement of activated factor IX in factor IX concentrates: Correlation with in vivo thrombogenicity
16. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an in vitro model of shear-dependent human thrombogenesis
17. A standardized model of microvenous thrombosis
18. Venous thrombosis generation by means of high-intensity focused ultrasound
19. The antithrombotic effect of thromboxane receptor antagonist HN 11500 on thrombus formation in laser thrombosis model and platelet function tests
20. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances
21. Vessel wall injury and arterial thrombosis induced by a photochemical reaction
22. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty
23. Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization
24. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE study
25. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
26. Influence of low molecular weight heparin on fibrin formation and platelet aggregation
27. Thrombin-antithrombin (TAT) complexes
28. Studies of human platelet alpha-granule release in vivo